ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 446,58
-0,05%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Infinity Pharmaceuticals Inc (INFI)

  7. Infinity Pharmaceuticals Inc (INFI) Actualités

INFI

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INFI
DateHeureSourceTitreSymboleSociété
13/09/202314h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
13/09/202300h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
10/08/202322h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202322h05Business WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202314h30Business WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202319h00Business WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202314h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202314h30Business WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202314h30Business WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202322h57Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
27/06/202314h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202318h08Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
13/04/202322h05Business WireInfinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer ResearchNASDAQ:INFIInfinity Pharmaceuticals Inc
28/03/202322h05Business WireInfinity Pharmaceuticals Reports Full Year 2022 Financial ResultsNASDAQ:INFIInfinity Pharmaceuticals Inc
28/03/202321h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202323h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202319h19PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
23/02/202313h00Business WireMEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
09/02/202317h36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INFIInfinity Pharmaceuticals Inc
22/11/202214h35Business WireInfinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare ConferenceNASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202218h40TipRanksAnalysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) and Infinity Pharma (INFI)NASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202213h07Business WireInfinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:INFIInfinity Pharmaceuticals Inc
14/11/202213h05Business WireInfinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of EganelisibNASDAQ:INFIInfinity Pharmaceuticals Inc
07/11/202214h25Business WireInfinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and WebcastNASDAQ:INFIInfinity Pharmaceuticals Inc
31/08/202213h00Business WireInfinity to Participate in Wells Fargo and H.C. Wainwright Investor ConferencesNASDAQ:INFIInfinity Pharmaceuticals Inc
12/08/202221h05TipRanksJonesTrading Reaffirms Their Hold Rating on Infinity Pharma (INFI)NASDAQ:INFIInfinity Pharmaceuticals Inc
09/08/202222h05Business WireInfinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:INFIInfinity Pharmaceuticals Inc
09/08/202221h52Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/08/202200h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
ACA
Credit Agricole
EU
VK
Vallourec
EU
SGO
Cie de SaintGobain
EU
HO
Thales
EU
RNO
Renault
EU
ML
Michelin
EU
EN
Bouygues
FTSE
UKX
FTSE 100
EU
AI
Air Liquide
EU
AF
Air FranceKLM
EU
CAP
Capgemini
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés